
2024

November 7, 2024
Living Wage Pledge

November 7, 2024
Raise Your Voice: the Annual DE&I Report

November 7, 2024
“Cancer & Work: Acting Together”: A Holistic Approach to Care for Sanofi Employees

August 29, 2024
Our Planet Care Strategy: Concrete Actions Towards Net Zero Emissions

April 30, 2024
Sanofi Global Health Unit: making a difference for our patients in low- and middle-income countries

April 30, 2024
Cancer and work: Sanofi supporting health and wellbeing in the workplace

February 9, 2024
Sanofi at COP28: supporting the decarbonization of healthcare systems

February 9, 2024
Sanofi Global Health Unit Impact fund invests in African healthcare start-ups

February 9, 2024
EMA gives positive opinion to Fexinidazole Winthrop as first oral treatment of sleeping sickness (rhodesiense)
2023

November 14, 2023
Impact brand: First Cardio-Metabolic medicines delivered to Djibouti and global NGOs

November 14, 2023
Sanofi inaugurates a new photovoltaic park in France

November 14, 2023
Progress on the partnership with Ghana’s Ministry of Health to improve access to diabetes care

September 21, 2023
Inclusivity at the forefront of our clinical trials

September 21, 2023
Sanofi CHC North America earns B Corp Certification

September 21, 2023
Pilot take-back programs for insulin pens launched in 2 European countries

June 1, 2023
Sanofi partnering with the Ghana Ministry of Health to improve affordable access to diabetes care

June 1, 2023
Sanofi capping its insulin to a $35 out-of-pocket costs in the U.S.

June 1, 2023
Net Zero towards 2045

March 9, 2023
Sanofi Global Health Unit impact fund first investment in Swipe RX

February 6, 2023
Transform the treatment of sleeping sickness

February 6, 2023